Bessos H, Wilson D W L, Metcalfe P, Allen D, Urbaniak S J
Scottish National Blood Transfusion Service, Edinburgh, UK.
Vox Sang. 2005 Aug;89(2):105-13. doi: 10.1111/j.1423-0410.2005.00672.x.
The aims of the 12th International Society of Blood Transfusion (ISBT) Platelet Immunology Workshop were to evaluate the proficiency of molecular human platelet antigen (HPA) genotyping and detection of platelet antibodies of unusual specificity or reactivity, to assess whether quantification of anti-HPA-1a is practicable, and to determine the variability of reagents and components used in the monoclonal antibody immobilization of platelet antigens assay (MAIPA).
Forty participants from 23 countries were sent 10 samples for DNA typing, five samples for antibody detection, a freeze-dried anti-HPA-1a standard, three samples for anti-HPA-1a quantification and a MAIPA method questionnaire.
The detection and identification of HPA antibodies varied from 2.7 to 95% of participants. The number of HPA genotyping errors per sample ranged from 0 to 3.96% per HPA loci. The majority of laboratories were able to assign an arbitrary number of units/ml of anti-HPA-1a activity to the unknown samples. The MAIPA questionnaire indicated a wide variation among participants, both in method and in reagents used.
The results obtained from this workshop highlighted deficiencies in testing regimes and identified a need for internationally available reference materials.
第12届国际输血协会(ISBT)血小板免疫学研讨会的目的是评估分子人类血小板抗原(HPA)基因分型的熟练度以及检测具有异常特异性或反应性的血小板抗体,评估抗HPA-1a定量是否可行,并确定用于血小板抗原单克隆抗体固定试验(MAIPA)的试剂和成分的变异性。
向来自23个国家的40名参与者发送了10份用于DNA分型的样本、5份用于抗体检测的样本、一份冻干抗HPA-1a标准品、3份用于抗HPA-1a定量的样本以及一份MAIPA方法问卷。
HPA抗体的检测与鉴定在2.7%至95%的参与者中存在差异。每个样本的HPA基因分型错误数量在每个HPA位点的0至3.96%之间。大多数实验室能够为未知样本指定任意数量的抗HPA-1a活性单位/毫升。MAIPA问卷表明参与者在方法和所用试剂方面存在很大差异。
本次研讨会获得的结果突出了检测方案中的不足,并确定了对国际可用参考材料的需求。